Published in Cardiovascular Week, April 25th, 2005
"The relationship between antiretroviral treatment of HIV infection, body fat distribution, insulin resistance, and very-low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL) apolipoprotein-B (apoB) kinetics was investigated in 55 HIV-infected patients taking two nucleoside analogs plus either a protease inhibitor (n=15) or a non-nucleoside reverse transcriptase inhibitor (n=25), 15 antiretroviral therapy-naive patients, and 12 HIV-negative controls.
"Compared with the controls, high-density lipoprotein cholesterol was reduced in all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.